Formulation and Optimization of Alogliptin-Loaded Polymeric Nanoparticles: In Vitro to In Vivo Assessment

The nano-drug delivery system has gained greater acceptability for poorly soluble drugs. Alogliptin (ALG) is a FDA-approved oral anti-hyperglycemic drug that inhibits dipeptidyl peptidase-4. The present study is designed to prepare polymeric ALG nanoparticles (NPs) for the management of diabetes. AL...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohanty, Dibyalochan, Gilani, Sadaf Jamal, Zafar, Ameeduzzafar, Imam, Syed Sarim, Kumar, Ladi Alik, Ahmed, Mohammed Muqtader, Jahangir, Mohammed Asadullah, Bakshi, Vasudha, Ahmad, Wasim, Eltayib, Eyman Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318982/
https://www.ncbi.nlm.nih.gov/pubmed/35889343
http://dx.doi.org/10.3390/molecules27144470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318982/
https://www.ncbi.nlm.nih.gov/pubmed/35889343
http://dx.doi.org/10.3390/molecules27144470

Ejemplares similares